News
2024 NATURE CONFERENCE - Boston, US
Shared Neoantigens For Colorectal Cancer Patients
Our study highlights the potential application of an off-the-shelf neoantigen panel to speed up the identification of immunogenic neoantigens and corresponding TCR constructs for cancer vaccine development.
2024 NATURE CONFERENCE - Boston, US
Enhancing Neoantigen Prioritization in Through T-Cell Receptor Repertoire Profiling
Our study highlight benefit of integrating T-cell receptor (TCR) repertoire profiles of tumor-infiltrating lymphocytes (TILs) as a key determinant of immunogenicity into neoantigen prediction and prioritization workflow.
ESMO Asia Congress 2023
Identification of Recurrent Neoantigens for the Development of Off-the-shelf Cancer Vaccines
We have developed a pipeline with both computational prediction tools and experimental validation assays, known as NEX-NEO to expedite the identification of immunogenic public neoantigens
ESMO Asia Congress 2023
T- Cell Receptor Repertoire Profiles of Tumor Infiltrating Lymphocytes Improves Neoantigen Prioritization
We integrate T-cell receptor (TCR) repertoire profiles of tumor-infiltrating lymphocytes (TILs) as a key determinant of immunogenicity into neoantigen prediction and prioritization